Clinical Trials Logo

Anxiety Disorders clinical trials

View clinical trials related to Anxiety Disorders.

Filter by:

NCT ID: NCT05718661 Recruiting - Anxiety Clinical Trials

The Effect of Virtual Reality on Preoperative Anxiety Before Abdominal Surgery

Start date: December 1, 2022
Phase: N/A
Study type: Interventional

Hospitalization, medical interventions to be performed, and uncertainties specific to surgical intervention create a certain level of anxiety in the patient. It is known that being in the hospital negatively affects the coping mechanisms of the patient. In the pre-surgical period, the nurse's practices that will facilitate the patient's coping with the situation and managing his anxiety have a positive effect on anxiety during and after surgery and on anxiety-related symptoms. For these reasons, it is aimed to determine the effect of virtual reality on pre-surgical anxiety in this study.The hypothesis of the study is that watching videos with virtual glasses will reduce preoperative anxiety.

NCT ID: NCT05718271 Recruiting - Anxiety Disorder Clinical Trials

Effects of Verbal Instructions on Fear Extinction and Extinction Retrieval

Start date: February 2, 2023
Phase: N/A
Study type: Interventional

The goal of this study is to examine if verbal instructions can improve fear extinction learning and extinction retrieval in patients with anxiety disorders (AD) and healthy controls.

NCT ID: NCT05717946 Recruiting - Depression Clinical Trials

The Influence of Probiotic Supplementation on the Severity of Anxiety and Depressive Symptoms, as Well as the Function and Composition of Gut Microbiota, Metabolic, Inflammation, and Oxidative Stress Markers in Patients With Depression

Start date: January 4, 2021
Phase: Phase 2
Study type: Interventional

The aim of this study is to gather empirical evidence which will enable to evaluate the impact of probiotic supplementation on the severity of anxiety and depressive symptoms, function, and composition of gut microbiota, metabolic parameters, inflammation, and oxidative stress markers in patients with diagnosed depressive disorders. The designed study will be prospective, randomized, placebo-controlled, and double-blind. The intervention period will last 8 weeks for each patient. The study will be conducted on 100 patients in total, who will be randomly divided into two groups, consisting of 50 patients each. Patients included in Group I (PRO-D) will receive one capsule daily containing a probiotic mixture at a daily dose of 3×109 colony-forming units (CFU). The probiotic will be composed of two bacteria strains: Lactobacillus helveticus Rosell®-52, Bifidobacterium longum Rosell®-175, and excipients: potato starch, magnesium stearate, and the capsule shell, made of hydroxypropylmethylcellulose. Patients included in Group II (PLC-D) will receive daily the same capsule, containing only excipients: potato starch, maltodextrin, and the capsule shell. The color, smell, and taste of the placebo will not be different from those included in the probiotic capsule. Patients will be considered compliant if they consume >= 80% of the supplements. The primary outcome measures will be the severity of depressive anxiety and stress symptoms assessed with Montgomery-Åsberg Depression Rating Scale (MADRS) and the Depression, Anxiety, Stress Scale (DASS) with subscales scores, the quality of life level assessed with the WHOQOL-BREF instrument. The secondary outcomes measures will include: blood pressure (BP), body mass index (BMI) and waist circumference (WC) measures, fasting glucose (fGlc), HDL cholesterol (HDL-C), triglycerides (TG), white blood cells count (WBC), neutrofiles, serum levels of C-reactive protein (CRP), the level of faecal SCFAs, faecal microbiota α-diversity and the level of oxidative stress parameters (total antioxidant capacity (TAC) and malondialdehyde (MDA)) in the blood serum.

NCT ID: NCT05717439 Recruiting - Clinical trials for Major Depressive Disorder

Feasibility and ML Training Investigation of the Senseye DT for Diagnosis of Adults With PTSD

Start date: March 1, 2023
Phase:
Study type: Observational

The aim of this study is to obtain data on the feasibility of the Senseye Diagnostic Tool (DT) to assess the presence and severity of post-traumatic stress disorder (PTSD) symptoms. The study will also collect data on Generalized Anxiety Disorder (GAD) and Major Depressive Disorder (MDD) to aid in assessing the presence and severity of these disorders both for the purpose of discerning them from PTSD and determining the feasibility of diagnosing them independently.

NCT ID: NCT05717231 Completed - Anxiety Clinical Trials

The Effect of Laughter Yoga on Tex Anxiety and Educational Stress

Start date: April 3, 2022
Phase: N/A
Study type: Interventional

The primary purpose of this study is to examine the effects of laughter therapy on tex anxiety and educational stress in 8th-grade students.

NCT ID: NCT05715593 Completed - Clinical trials for Health Education, COVID-19, Quarantine, Anxiety, Pandemic

The Effectiveness of a Health Education Intervention to Reduce Anxiety in Quarantined COVID-19 Patients

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

we aimed to assess the impact of health education on the anxiety level of COVID-19 patients during the isolation period.

NCT ID: NCT05715034 Completed - Depression Clinical Trials

Single-Session Web-Based Training in Self-Compassion

Start date: February 27, 2023
Phase: N/A
Study type: Interventional

Two-arm, parallel group randomized clinical trial conducted via Mturk comparing a single-session web-based intervention called Compassionate Care versus a control intervention (nature videos with relaxing music) for adults with moderate-to-severe stress, depression and/or anxiety symptoms.

NCT ID: NCT05712954 Recruiting - Pain Clinical Trials

The Effect of Using Music and Natural Landscape Paintings on Pain Level, Anxiety and Analgesic Use of Women During HSG

Start date: January 13, 2023
Phase: N/A
Study type: Interventional

The study was planned as a randomized controlled study in order to evaluate the use of music and natural scenery paintings in women who underwent HSG procedure, their pain level, anxiety and post-procedure analgesic use.

NCT ID: NCT05712057 Recruiting - Anxiety Disorders Clinical Trials

Neurostimulation Versus Therapy for Problems With Emotions

Start date: May 15, 2023
Phase: N/A
Study type: Interventional

The primary goal of this clinical trial is to evaluate the unique neural and behavioral effects of a one-session training combining emotion regulation skills training, with excitatory repetitive transcranial magnetic stimulation (rTMS) over the dorsolateral prefrontal cortex (dlPFC). The secondary aim is to identify key changes in the emotion regulation neural network following the combined intervention versus each of the components alone. The third aim is to explore personalized biomarkers for response to emotion regulation training. Participants will undergo brain imaging while engaging in an emotional regulation task. Participants will be randomly assigned to learn one of two emotion regulation skills. Participants will be reminded of recent stressors and will undergo different types of neurostimulation, targeted using fMRI (functional MRI) results. Participants who may practice their emotion regulation skills during neurostimulation in a one-time session. Following this training, participants will undergo another fMRI and an exit interview to assess for immediate neural and behavioral changes. Measures of emotion regulation will be assessed at a one week and a one month follow up visit.

NCT ID: NCT05708586 Terminated - Pain Clinical Trials

Virtual Reality Decreases Child Anxiety and Pain as Well as Caregiver Anxiety and Pain Perception During Orthopaedic Clinic Office Procedures

Start date: December 8, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to demonstrate that the use of a virtual reality experience can decrease child and caregiver anxiety and pain for simple orthopaedic office procedures.